Gleevec (imatinib) is a targeted tyrosine kinase inhibitor used to treat several cancers, most notably Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). It also treats Gastrointestinal Stromal Tumors (GIST), dermatofibrosarcoma protuberans, and certain myelodysplastic and myeloproliferative diseases by blocking specific cancer-promoting proteins.
$171.00–$1,602.00Price range: $171.00 through $1,602.00Select options
This product has multiple variants. The options may be chosen on the product page
$184.00–$1,184.00Price range: $184.00 through $1,184.00Select options
This product has multiple variants. The options may be chosen on the product page
$127.00–$3,658.00Price range: $127.00 through $3,658.00Select options
This product has multiple variants. The options may be chosen on the product page